Moody National Bank Trust Division Dexcom Inc Transaction History

Moody National Bank Trust Division

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$86.06 - $137.93 $5,507 - $8,827	64 Added 1.4%	4,645 $433,000
Q4 2022 Jan 11, 2023	BUY	$84.98 - $122.67 $3,654 - $5,274	43 Added 0.95%	4,581 $519,000
Q3 2022 Oct 05, 2022	BUY	$76.35 - $94.18 $23,363 - $28,819	306 Added 7.23%	4,538 $365,000
Q2 2022 Jul 07, 2022	BUY	$67.99 - $132.89 $287,733 - $562,390	4,232 New	4,232 $315,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.